TOTAL $ 170,661 $ 136,958 24.6 13.9 10.7
TOTAL INTERNATIONAL $ 915,717 $ 780,900 17.3 6.5 10.8
(1) Cell Analysis consists of the Immunocytometry Systems and the
Pharmingen units that were previously reported separately.
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND UNITS
Three Months Ended December 31, (continued)
(Unaudited; Amounts in thousands)
Total
% Change
FX FX
2007 2006 Reported Neutral Impact
BD MEDICAL
Medical Surgical Systems $ 498,811 $ 467,751 6.6 2.0 4.6
Diabetes Care 189,387 168,686 12.3 7.2 5.1
Pharmaceutical Systems 201,941 172,940 16.8 7.6 9.2
Ophthalmic Systems 19,145 16,870 13.5 6.0 7.5
TOTAL $ 909,284 $ 826,247 10.0 4.3 5.7
BD DIAGNOSTICS
Preanalytical Systems $ 271,469 $ 240,072 13.1 8.0 5.1
Diagnostic Systems 251,282 202,328 24.2 19.5 4.7
TOTAL $ 522,751 $ 442,400 18.2 13.2 5.0
BD BIOSCIENCES
Cell Analysis (1) $ 205,113 $ 168,991 21.4 19.9 1.5
Discovery Labware 68,619 63,888 7.4 2.9 4.5
TOTAL $ 273,732 $ 232,879 17.5 11.2 6.3
TOTAL REVENUES $1,705,767 $1,501,526 13.6 8.0 5.6
(1) Cell Analysis consists of the Immunocytometry Systems and the
Pharmingen units that were previously reported separately.
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2008 PR Newswire. All rights reserved |